{
  "age_at_diagnosis": "Patient age at time of breast cancer diagnosis (years)",
  "inferred_menopausal_state": "Menopausal status inferred from age and clinical records (Pre/Post)",
  "type_of_breast_surgery": "Surgical procedure performed (mastectomy vs. breast-conserving surgery)",
  "chemotherapy": "Whether patient received chemotherapy treatment (Yes/No)",
  "hormone_therapy": "Whether patient received hormone therapy treatment (Yes/No)",
  "radio_therapy": "Whether patient received radiation therapy treatment (Yes/No)",
  "cancer_type": "Primary cancer diagnosis: Breast Cancer or Breast Sarcoma",
  "cancer_type_detailed": "Detailed histological classification: Invasive Ductal Carcinoma, Mixed Ductal and Lobular Carcinoma, Invasive Lobular Carcinoma, Invasive Mixed Mucinous Carcinoma, or Metaplastic Breast Cancer",
  "tumor_other_histologic_subtype": "Histologic subtype based on microscopic examination: Ductal/NST, Mixed, Lobular, Tubular/Cribriform, Mucinous, Medullary, Metaplastic, or Other",
  "cellularity": "Proportion of tumor cells in the specimen and their spatial arrangement into clusters (assessed post-chemotherapy)",
  "neoplasm_histologic_grade": "Tumor grade (1-3) determined by pathological assessment of cell morphology and aggressiveness: Grade 1 (well-differentiated), Grade 2 (moderately differentiated), Grade 3 (poorly differentiated)",
  "tumor_size": "Maximum diameter of the primary tumor (millimeters)",
  "tumor_stage": "TNM stage grouping indicating extent of cancer spread (Stage 0-IV)",
  "primary_tumor_laterality": "Anatomical side of primary tumor: Right or Left breast",
  "lymph_nodes_examined_positive": "Number of regional lymph nodes with confirmed metastatic involvement (determined by surgical sampling and pathological examination)",
  "nottingham_prognostic_index": "Prognostic score calculated from tumor size, lymph node involvement, and histologic grade; used to estimate survival outcome and guide treatment decisions",
  "oncotree_code": "Standardized cancer type code from the OncoTree ontology enabling consistent classification across clinical and research contexts",
  "er_status": "Estrogen receptor expression status: Positive (ER+) indicates tumor cells express estrogen receptors and may respond to hormone therapy",
  "er_status_measured_by_ihc": "Estrogen receptor status determined by immunohistochemistry (IHC), a pathological staining technique that detects receptor proteins",
  "pr_status": "Progesterone receptor expression status: Positive (PR+) indicates tumor cells express progesterone receptors",
  "her2_status": "HER2 status: Positive (HER2+) indicates overexpression or amplification, making tumor eligible for targeted therapies",
  "her2_status_measured_by_snp6": "HER2 status determined by SNP6 array, detecting gene copy number variations",
  "pam50_+_claudin-low_subtype": "Intrinsic molecular subtype based on PAM50 gene expression signature plus Claudin-low classification",
  "3-gene_classifier_subtype": "Simplified molecular classification based on ER, HER2, and proliferation index",
  "integrative_cluster": "METABRIC integrative cluster (IntClust 1-10): classification system combining copy number alterations, gene expression, and clinical features",
  "overall_survival_months": "Time from diagnosis to death or last follow-up (months)",
  "overall_survival": "Vital status at last follow-up: Living or Deceased",
  "death_from_cancer": "Whether death was attributed to breast cancer",
  "mutation_count": "Total number of genes with detected mutations in this patient",
  "patient_id": "Unique anonymous identifier for each patient",
  "cohort": "Study cohort identifier indicating data collection site or batch"
}
